Sectoral Asset Management Inc Esperion Therapeutics, Inc. Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$31.18 - $52.71 $121,602 - $205,569	-3,900 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$30.04 - $51.31 $117,156 - $200,109	3,900 New	3,900 $200,000
Q4 2018 Feb 12, 2019	SELL	$36.99 - $59.11 $3.55 Million - $5.68 Million	-96,100 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $4.66 Million - $5.88 Million	-114,368 Reduced 54.34%	96,100 $4.26 Million
Q2 2018 Aug 13, 2018	BUY	$36.2 - $76.4 $2.82 Million - $5.96 Million	78,000 Added 58.88%	210,468 $8.25 Million
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $7.2 Million - $8.81 Million	109,135 Added 467.73%	132,468 $9.58 Million
Q4 2017 Feb 13, 2018	BUY	$43.47 - $67.43 $1.01 Million - $1.57 Million	23,333	23,333 $1.54 Million

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $171M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.